# Drug Use Investigation for IMIGRAN Tablet

> **NCT01376141** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 3571 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Sumatriptan

## Key facts

- **NCT ID:** NCT01376141
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** 2005-02
- **Final completion:** 2005-11
- **Target enrollment:** 3571 (ACTUAL)
- **Last updated:** 2017-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01376141

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01376141, "Drug Use Investigation for IMIGRAN Tablet". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01376141. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*